R01 CA129966/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2009	4
2010	1
2011	3
2012	5
2013	9
2014	4
2024	0

1

Russell SJ, Peng KW, Bell JC. Russell SJ, et al. Nat Biotechnol. 2012 Jul 10;30(7):658-70. doi: 10.1038/nbt.2287. Nat Biotechnol. 2012. PMID: 22781695 Free PMC article. Review.

2

Measles virus for cancer therapy.

Russell SJ, Peng KW. Russell SJ, et al. Curr Top Microbiol Immunol. 2009;330:213-41. doi: 10.1007/978-3-540-70617-5_11. Curr Top Microbiol Immunol. 2009. PMID: 19203112 Free PMC article. Review.

3

Antibody neutralization of retargeted measles viruses.

Lech PJ, Pappoe R, Nakamura T, Tobin GJ, Nara PL, Russell SJ. Lech PJ, et al. Virology. 2014 Apr;454-455:237-46. doi: 10.1016/j.virol.2014.01.027. Epub 2014 Mar 14. Virology. 2014. PMID: 24725950 Free PMC article.

4

Curative one-shot systemic virotherapy in murine myeloma.

Naik S, Nace R, Federspiel MJ, Barber GN, Peng KW, Russell SJ. Naik S, et al. Leukemia. 2012 Aug;26(8):1870-8. doi: 10.1038/leu.2012.70. Epub 2012 Mar 19. Leukemia. 2012. PMID: 22425894 Free PMC article.

5

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines.

Kumar SK, Mikhael JR, Buadi FK, Dingli D, Dispenzieri A, Fonseca R, Gertz MA, Greipp PR, Hayman SR, Kyle RA, Lacy MQ, Lust JA, Reeder CB, Roy V, Russell SJ, Short KE, Stewart AK, Witzig TE, Zeldenrust SR, Dalton RJ, Rajkumar SV, Bergsagel PL. Kumar SK, et al. Mayo Clin Proc. 2009 Dec;84(12):1095-110. doi: 10.4065/mcp.2009.0603. Mayo Clin Proc. 2009. PMID: 19955246 Free PMC article.

6

Enhancing cytokine-induced killer cell therapy of multiple myeloma.

Liu C, Suksanpaisan L, Chen YW, Russell SJ, Peng KW. Liu C, et al. Exp Hematol. 2013 Jun;41(6):508-17. doi: 10.1016/j.exphem.2013.01.010. Epub 2013 Feb 8. Exp Hematol. 2013. PMID: 23403007 Free PMC article.

7

Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions.

Hadac EM, Federspiel MJ, Chernyy E, Tuzikov A, Korchagina E, Bovin NV, Russell S, Henry SM. Hadac EM, et al. J Virol Methods. 2011 Sep;176(1-2):78-84. doi: 10.1016/j.jviromet.2011.06.005. Epub 2011 Jun 14. J Virol Methods. 2011. PMID: 21703308

8

Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virus.

Ayala-Breton C, Russell LO, Russell SJ, Peng KW. Ayala-Breton C, et al. J Virol. 2014 Aug;88(15):8332-9. doi: 10.1128/JVI.03823-13. Epub 2014 May 14. J Virol. 2014. PMID: 24829351 Free PMC article.

9

Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spread.

Ayala-Breton C, Suksanpaisan L, Mader EK, Russell SJ, Peng KW. Ayala-Breton C, et al. Mol Ther. 2013 Oct;21(10):1930-7. doi: 10.1038/mt.2013.164. Epub 2013 Jul 11. Mol Ther. 2013. PMID: 23842448 Free PMC article.

10

Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.

Lech PJ, Tobin GJ, Bushnell R, Gutschenritter E, Pham LD, Nace R, Verhoeyen E, Cosset FL, Muller CP, Russell SJ, Nara PL. Lech PJ, et al. PLoS One. 2013;8(1):e52306. doi: 10.1371/journal.pone.0052306. Epub 2013 Jan 3. PLoS One. 2013. PMID: 23300970 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year